Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-20 | Cyteir Therapeutics, Inc. | Leonard Braden Mi...
(AtLeastTenPercentOwner) |
P | Common Stock, par value $0.001 per share | A | 170589 | $2.95 - $2.95 | $503,237 |
| 2023-11-20 | Cyteir Therapeutics, Inc. | RENSCHLER MARKUS MD
(President and CEO) |
M | Common Stock | A | 8840 | $1.20 - $1.69 | $13,696 |
| 2023-11-20 | Cyteir Therapeutics, Inc. | RENSCHLER MARKUS MD
(President and CEO) |
M | Common Stock | A | 84637 | $1.20 - $1.69 | $129,365 |
| 2023-11-20 | Cyteir Therapeutics, Inc. | Gaiero David G
(Chief Financial Officer) |
M | Common Stock | A | 73940 | $1.68 - $1.69 | $124,432 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |